Mike DeLaroche
EVP Business Development & Integrated Strategy
专长:
Mike is helping EVERSANA lead the way in end-to-end, integrated commercialization for the life sciences industry. He leverages more than 30 years of experience across pharma to drive EVERSANA COMPLETE Commercialization, the industry’s only complete commercialization solution. Mike has extensive experience working with emerging and mid-size pharma companies to develop strategy and tactics for successful launches. Throughout his career, he has worked at Johnson & Johnson, Cardinal Health and Syneos Health.
Mike holds an MBA from Pepperdine University and received his bachelor’s degree from San Diego State University.
Articles by Mike DeLaroche
Against the Odds: Managing the Uncertainty of FDA Approval for Emerging Companies
47% of FDA applications are delayed for resourceful larger pharma. The situation is even worse for emerging pharma, with 78% of FDA applications being delayed. Pharmaceutical companies have seen a steady and daunting rise in FDA approval delays for their new products over the past decade. From 2010-2021 the percentage of approved drugs referred to […]